Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early‐stage lung adenocarcinoma.

MLA

Hong, Tae H., et al. “Different Prognostic Role of EGFR Mutation According to the IASLC Histological Grade in Patients with Resected Early‐stage Lung Adenocarcinoma.” Histopathology, vol. 83, no. 2, Aug. 2023, pp. 168–77. EBSCOhost, https://doi.org/10.1111/his.14894.

APA

Hong, T. H., Hwang, S., Choi, Y., Lee, G., Park, S., Ahn, M., Lee, Y., Jeon, Y. J., Lee, J., Shin, S., Park, S. Y., Cho, J. H., Choi, Y. S., Kim, J., Shim, Y. M., Cho, J., & Kim, H. K. (2023). Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early‐stage lung adenocarcinoma. Histopathology, 83(2), 168–177. https://doi.org/10.1111/his.14894

Chicago

Hong, Tae H, Soohyun Hwang, Yoon‐La Choi, Genehee Lee, Sehhoon Park, Myung‐Ju Ahn, Yoonseo Lee, et al. 2023. “Different Prognostic Role of EGFR Mutation According to the IASLC Histological Grade in Patients with Resected Early‐stage Lung Adenocarcinoma.” Histopathology 83 (2): 168–77. doi:10.1111/his.14894.